Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer

被引:12
作者
Elezkurtaj, Sefer [1 ]
Moser, Lutz [2 ]
Budczies, Jan [1 ]
Mueller, Alice Josephine [3 ]
Blaeker, Hendrik [1 ]
Buhr, Heinz Johannes [3 ]
Dietel, Manfred [1 ]
Kruschewski, Martin [3 ]
机构
[1] Charite Univ Med Berlin, Inst Pathol, D-10117 Berlin, Germany
[2] Charite Univ Med Berlin, Klin & Hochsch Ambulanz Radioonkol & Strahlenther, D-12200 Berlin, Germany
[3] Charite Univ Med Berlin, Chirurg Klin & Hochsch Ambulanz 1, Klink Allgemein Gefass & Thoraxchirurg, D-12200 Berlin, Germany
关键词
Rectal cancer; Neoadjuvant therapy; Regression grading; LYMPH-NODE STATUS; COMPLETE PATHOLOGICAL RESPONSE; HIGH-DOSE CHEMORADIATION; PREOPERATIVE CHEMORADIOTHERAPY; TUMOR-REGRESSION; PROGNOSTIC VALUE; CLINICAL IMPACT; SURVIVAL; DISEASE; RADIOCHEMOTHERAPY;
D O I
10.1016/j.prp.2013.04.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Histopathological regression grading has been shown to predict outcome in chemoradiated rectal cancer. Lymph node spread is still considered the most important single prognostic parameter. Therefore, we investigated the association of regression grading with tumor spread in a single center retrospective cohort. 102 consecutive patients who had undergone neoadjuvant therapy for rectal adenocarcinoma were included. Surgery was performed, including total mesorectal excision. Pathological examination included UICC staging and Dworak's five-tier tumor regression grading. Histological complete response was achieved in 16.7% of cases. Dworak's regression grading and a simplified two tier scheme both correlated excellently with ypT, ypN and UICC stage. However, cases with poor histological response were strongly represented in ypN0. Tumor regression grading is a reliable method for assessment of response to neoadjuvant therapy, but the optimal cut-off for separating good and poor response remains to be established based on clinical outcome. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:424 / 428
页数:5
相关论文
共 45 条
  • [1] A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy
    Beddy, D.
    Hyland, J. M. P.
    Winter, D. C.
    Lim, C.
    White, A.
    Moriarty, M.
    Armstrong, J.
    Fennelly, D.
    Gibbons, D.
    Sheahan, K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (12) : 3471 - 3477
  • [2] Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications
    Berger, C
    deMuret, A
    Garaud, P
    Chapet, S
    Bourlier, P
    ReynaudBougnoux, A
    Dorval, E
    deCalan, L
    Huten, N
    leFloch, O
    Calais, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03): : 619 - 627
  • [3] The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer
    Berho, M.
    Oviedo, M.
    Stone, E.
    Chen, C.
    Nogueras, J.
    Weiss, E.
    Sands, D.
    Wexner, S.
    [J]. COLORECTAL DISEASE, 2009, 11 (03) : 254 - 258
  • [4] Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial
    Bujko, Krzysztof
    Michalski, Wojciech
    Kepka, Lucyna
    Nowacki, Marek P.
    Nasierowska-Guttmejer, Anna
    Tokar, Piotr
    Dymecki, Dariusz
    Pawlak, Mariusz
    Lesniak, Tadeusz
    Richter, Piotr
    Wojnar, Andrzej
    Chmielik, Ewa
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02): : 369 - 377
  • [5] A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation
    Chetty, Runjan
    Gill, Pelvender
    Govender, Dhirendra
    Bateman, Adrian
    Chang, Hee Jin
    Driman, David
    Duthie, Fraser
    Gomez, Marisa
    Jaynes, Eleanor
    Lee, Cheok Soon
    Locketz, Michael
    Mescoli, Claudia
    Rowsell, Corwyn
    Rullier, Anne
    Serra, Stefano
    Shepherd, Neil
    Szentgyorgyi, Eva
    Vajpeyi, Rajkumar
    Wang, Lai Mun
    [J]. VIRCHOWS ARCHIV, 2012, 460 (02) : 151 - 155
  • [6] Clinical impact of lymph node status in rectal cancer
    Colombo, P. E.
    Patani, N.
    Bibeau, F.
    Assenat, E.
    Bertrand, M. M.
    Senesse, P.
    Rouanet, P.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2011, 20 (04): : E227 - E233
  • [7] Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation and Surgery
    de Campos-Lobato, Luiz Felipe
    Geisler, Daniel P.
    Moreira, Andre da Luz
    Stocchi, Luca
    Dietz, David
    Kalady, Matthew F.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (03) : 444 - 450
  • [8] Pathological features of rectal cancer after preoperative radiochemotherapy
    Dworak, O
    Keilholz, L
    Hoffmann, A
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1997, 12 (01) : 19 - 23
  • [9] The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma
    Edden, Y.
    Wexner, S. D.
    Berho, M.
    [J]. COLORECTAL DISEASE, 2012, 14 (05) : 555 - 561
  • [10] Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy
    Evans, Jessica
    Patel, Uday
    Brown, Gina
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2011, 21 (03) : 169 - 177